Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0000950170-25-048847

Options or other derivatives

  • Chief Scientific Officer acquired 70,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vincent Loic A Chief Scientific Officer 2025-04-01 Grant or award · Stock Option (Right to Buy) +70,000 70,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…